KP Tissue Inc. (TSE:KPT - Get Free Report) shares hit a new 52-week high during mid-day trading on Monday . The stock traded as high as C$9.27 and last traded at C$9.27, with a volume of 6359 shares changing hands. The stock had previously closed at C$9.16.
Analyst Ratings Changes
Several equities analysts have recently issued reports on KPT shares. Desjardins lifted their price target on KP Tissue from C$8.50 to C$9.50 and gave the company a "hold" rating in a research note on Thursday, May 22nd. National Bankshares lifted their price target on KP Tissue from C$8.50 to C$9.50 and gave the company a "sector perform" rating in a research note on Thursday, May 22nd. Finally, TD Securities lifted their price target on KP Tissue from C$8.00 to C$9.00 and gave the company a "hold" rating in a research note on Thursday, May 22nd.
Check Out Our Latest Research Report on KPT
KP Tissue Trading Down 0.1%
The company has a 50 day moving average price of C$8.68 and a 200-day moving average price of C$8.25. The company has a market cap of C$92.85 million, a P/E ratio of 14.54, a price-to-earnings-growth ratio of -0.88 and a beta of 0.37.
KP Tissue Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 15th will be issued a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a dividend yield of 7.75%. The ex-dividend date of this dividend is Monday, June 30th. KP Tissue's dividend payout ratio (DPR) is 112.73%.
KP Tissue Company Profile
(
Get Free Report)
KP Tissue Inc, through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through two segments, Consumer and Away-From-Home. It offers bathroom and facial tissues, paper towels, and napkins.
Recommended Stories
Before you consider KP Tissue, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KP Tissue wasn't on the list.
While KP Tissue currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.